Latest News
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
6 July 2026 - Northwest Biotherapeutics (NWBio) (OTCQB:NWBO), a US biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, has announced that Dr. Marnix Bosch, the company's chief technical officer, made a ...
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
6 July 2026 - The Development Center for Biotechnology (DCB), a research institute in Taiwan, said on Friday that six Taiwanese biomedical startups held more than 100 one-on-one business meetings with global pharmaceutical companies, investors, indus...
Brii Bio reports Phase 2 end-of-treatment data in chronic hepatitis B
6 July 2026 - Chinese biotechnology company Brii Biosciences Limited (Brii Bio) (HK:2137) has announced end-of-treatment (EOT) results from its ongoing Phase 2b ENRICH and ENHANCE studies investigating sequential versus concurrent combination regimen...
Sanyou Bio and Baiyunshan Xihe partner to develop radiopharmaceuticals and radiodiagnostics
6 July 2026 - Chinese pharmaceutical companies Sanyou Biopharmaceutical Co Ltd and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co Ltd announced on Saturday that they have entered into a strategic cooperation agreement.The partnership will focus o...
Frontier IP portfolio company InSignals wins EU grant and launches Parkinson's app
6 July 2026 - Frontier IP Group Plc (AIM: FIPP), a company that commercialises intellectual property, announced on Monday that its portfolio company inSignals Neurotech has secured a EUR317,762 grant co-financed by the European Union under the Portug...